GENEVA, June 19 -- MIRATI THERAPEUTICS, INC. filed a patent application (US2025/014898) for “CRYSTALLINE FORMS OF (R)-6-CHLORO-3-((1-(2-CYANO-7-METHYL-3-MORPHOLINOQUINOXALIN-5-YL)ETHYL)AMINO)PICOLINIC ACID”. With publication no. WO/2025/171194, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: C07D 401/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....